INDOVAX Pvt Ltd is engaged in the production of quality poultry biologicals since 1991. Since then, INDOVAX with its research focused at product development for Indian (tropical) conditions and a unique holistic approach to poultry disease challenges, as distinct from a product approach, has helped the Indian poultry farmer in overcoming the ever-increasing and challenging disease problems.
INDOVAX scientists are continuously on hunt on the part of to search for newer solutions and, thereby, counter the new emerging threats to poultry. The company launched many vaccines like Marek's frozen MD vaccine (1991), Intermediate Strain of IBD vaccine (1993) and EDS'76 inactivated vaccine (1994).
INDOVAX doesn't just sell vaccines, it sells complete vaccination programs that are area-specific and even customer-specific. This makes INDOVAX a unique company in the poultry industry. INDOVAX continues to expand and has established itself as India's leading poultry biological company. Its products are, in most cases, the only choice for poultry farmers, veterinarians and consultants.
Spread over an area of 14 acres in a completely poultry-free zone, INDOVAX has a modern state-of-the-art facility designed to the global standards. The company's sales is about Rs 30 crore.